منابع مشابه
Totally biological composite aortic stentless valved conduit for aortic root replacement: 10-year experience
OBJECTIVES To retrospectively analyze the clinical outcome of a totally biological composite stentless aortic valved conduit (No-React® BioConduit) implanted using the Bentall procedure over ten years in a single centre. METHODS Between 27/10/99 and 19/01/08, the No-React® BioConduit composite graft was implanted in 67 patients. Data on these patients were collected from the in-hospital datab...
متن کاملSevere calcification of a Shelhigh stentless valved conduit.
A 74-year old patient developed severe aortic valve regurgitation 11 years following root replacement using a stentless Shelhigh tube-graft. Computed tomography scan showed a heavily calcified aortic conduit (Fig. 1), although the company claims that detoxification process eliminates residual glutaraldehyde and ensures less calcification in the long term. The patient underwent successful transa...
متن کاملDisintegration of a stentless valved conduit causing contained rupture of the aortic root.
rom the Departments of Cardiology, †Radiology, nd ‡Cardiovascular Surgery, ichat Hospital, Paris, rance. anuscript received ugust 24, 2009; ccepted September 9, 2009. A40-year-old-man required, in 2007, the implantation of a stentless valved conduit for destructive aortic endocarditis. In 2009, he presented with dyspnea and a new aortic regurgitation murmur, but no argument for endocarditis. Tr...
متن کاملReplacement of the ascending aorta, aortic root, and valve with a novel stentless valved conduit.
PURPOSE Biologic valved-conduit grafts avoid the need for anticoagulation and can exploit the excellent hemodynamic performance of stentless valves. Incorporation of sinuses of Valsalva into the neoaortic root can improve the function of the stentless valves. DESCRIPTION Here we present a novel prefabricated stentless valved conduit incorporating sinuses of Valsalva and describe the technique...
متن کاملPreassembled stentless valved-conduit for the replacement of the ascending aorta and aortic root.
Here we report the early clinical results of a new preassembled stentless valved-conduit incorporating artificial sinuses of Valsalva (BioValsalva). This new composite conduit incorporates a stentless porcine aortic valve (Elan, Vascutek Terumo, UK) suspended within a triple-layered vascular conduit (Triplex, Vascutek Terumo, UK) constructed with sinuses of Valsalva. Between December 2006 and J...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Journal of Cardio-Thoracic Surgery
سال: 2001
ISSN: 1873-734X,1010-7940
DOI: 10.1016/s1010-7940(01)01004-1